Disposition of alendronate following local delivery in a rat jaw

Journal of Periodontology

Volumn 70, Issue 8, 1999, Pages 893-895

  Yaffe, Avinoam ^a   Binderman, I ^b   Breuer, E ^c   Pinto, T ^d   Golomb, G ^d  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d NONE

Author keywords

Alendronate therapeutic use; Animal studies; Bone resorption prevention and control; Drug delivery systems; Radioactive tracers

Indexed keywords

ALENDRONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DISPOSITION; MANDIBLE; MOLAR TOOTH; NONHUMAN; OSTEOLYSIS; PREMOLAR TOOTH; RAT; TIBIA; TOPICAL DRUG ADMINISTRATION;

ABSORPTION; ADMINISTRATION, TOPICAL; ALENDRONATE; ANIMALS; BONE RESORPTION; MANDIBLE; OSTEOTOMY; RATS; RATS, WISTAR; TIBIA; TISSUE DISTRIBUTION;

EID: 0032773505     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.1999.70.8.893     Document Type: Article

References (19)

1. Sato M, Grasser W, Endo E, et al. Alendronate localization in rat bone and effects on osteoclast ultrastructure. J Clin Invest 1991;88:2095-2105.
2. Heikkinen JE, Selander KS, Laitinen K, Arnala I, Kalervo Vaananen H. Short-term intravenous bisphosphonates in prevention of postmenopausal bone loss. J Bone Miner Res 1997;12:103-110.
3. Lieberman UA, Weiss SR, Broll J, et al. Effect of oral alendronate on bone mineral density and incidence of fractures in postmenopausal osteoporosis. The New Engl Med 1995;333:1437-1443.
4. Fleisch H. Bisphosphonates: Pharmacology and use in the treatment of tumor-induced hypercalcemic and metastatic bone disease. Drugs 1991;42:919-944.
5. Castren-Kortekangas P, Loyttyniemi E, Liukko-Sipi S, Juhakoski A, Smal J, Laitinen K. Pooling of clodronate urinary excretion data: a new pharmacokinetic method to study drugs with highly variable gastro-intestinal absorption. J Bone Miner Res 1997;12:66-71.
6. Bohannan HM. Studies in the alteration of vestibular depth. I. Complete denudation. J Periodontol 1962; 33:120-128.
7. Bohannan HM. Studies in alteration of vestibular depth. II. Periosteum retention. J Periodontol 1962;33:354-359.
8. Wilderman MH. Repair after a periosteal retention procedure. J Periodontol 1963;34:487-503.
9. Staffilino H, Levy S, Gargiulo A. Histologic study of cellular mobilization and repair following a periosteal retention operation via split thickness mucogingival flap surgery. J Periodontol 1966;37:117-131.
10. Pfeifer JS. The growth of gingival tissue over denuded bone. J Periodontol 1963;34:10-16.
11. Pfeifer JS. The reaction of alveolar bone to flap procedure in man. Periodontics 1965;3:135-140.
12. Ramfjord SF, Costich ER. Healing after exposure of periosteum on the alveolar process. J Periodontol 1968; 39:199-207.
13. Bergstrom J, Henrikson CO. Quantitative longitudinal study of alveolar bone tissue in man. J Periodont Res 1970;5:237-247.
14. Yaffe A, Fine N, Alt I, Binderman I. Effect of Bisphosphonate on alveolar bone resorption following mucoperiosteal flap surgery in the mandible of rats. J Periodontal 1995;66:999-1003.
15. Yaffe A, Iztkovich M, Earon Y, Alt I, Lilov R, Binderman I. Local delivery of the amino bisphosphonate, alendronate, prevents the resorptive phase of alveolar bone following mucoperiosteal flap surgery in rats. J Periodontol 1997;68:884-889.
16. Yaffe A, Fine N, Binderman I. Regional accelerated phenomenon (R.A.P) in the mandible following mucoperiosteal flap surgery. J Periodontol 1994;65:79-83.
17. Frost MH. The biology of fracture healing: An overview for clinicians. Part I. Clin Orthop 1989;248:283-293.
18. Frost MH. The biology of fracture healing: An overview for clinicians. Part II. Clin Orthop 1989;248:294-309.
19. 3H-etidronate in rat and mouse bones. Bone 1996;19:281-290